Skip to main content
. 2016 Nov 7;22(41):9172–9185. doi: 10.3748/wjg.v22.i41.9172

Table 1.

Demographic, clinical and laboratory characteristics of patients with or without bacterial infections

Non-infected Infected P value
n 141 75
Gender (male/female) 77/64 41/34 NS
Age (yr) 57.3 ± 10.7 58.1 ± 9.7 NS
Child-Pugh score 6.9 ± 1.7 9.3 ± 2.2 < 0.001
Child-Pugh stage, n (%)
A 58 (41.1) 6 (8.0) < 0.001
B 65 (46.1) 28 (37.3)
C 18 (12.8) 41 (54.7)
MELD score 12.3 ± 4.1 19.1 ± 9.1 < 0.001
Serum bilirubin (μmol/L) 41.4 ± 38.3 124.1 ± 147.4 < 0.001
Serum albumin (g/L) 35.4 ± 7.1 28.1 ± 6.5 < 0.001
INR 1.3 ± 0.2 1.6 ± 0.5 < 0.001
Serum creatinine (μmol/L) 83.8 ± 74.3 131.2 ± 129.9 < 0.001
Ascites present, n (%) 58 (41.1) 59 (78.7) < 0.001
HCC, n (%) 4 (2.8) 11 (14.7) 0.003
Comorbidities present, n (%) 72 (51.1) 45 (60.0) NS
Type of bacterial infections, n (%)
UTI 25 (29.4)
SBP 20 (23.5)
Pneumonia 18 (21.2)
SSTI 4 (4.7)
Miscellaneous 18 (21.2)
Multiple 9 (10.6)
Acute phase proteins, median (IQR)
Presepsin (pg/mL) Overall 477 (332-680) 1002 (575-2149) < 0.001
OF absent OF present 710 (533-1277) 2357 (1398-3666) < 0.001
CRP (mg/L) Overall 4.6 (1.8-8.8) 30.1 (11.3-57.4) < 0.001
OF absent OF present 25 (9.6-40.5) 52.2 (23.4-84) 0.027
PCT (μmol/L) Overall 0.1 (0.1-0.2) 0.4 (0.1-1.2) < 0.001
OF absent OF present 0.2 (0.1-0.5) 1.7 (0.6-5.3) < 0.001

Data are presented as mean ± SD or n (%) if not otherwise indicated. CRP: C-reactive protein; HCC: Hepatocellular carcinoma; IQR: Interquartile range; INR: International normalized ratio; MELD: Model for end-stage liver disease score; NS: Non-significant; PCT: Procalcitonin; SD: Standard deviation; UTI: Urinary tract infection; SBP: Spontaneous bacterial peritonitis; SSTI: Skin and soft tissue infection.